Nicotine Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, 251 Bayview Boulevard, Baltimore, MD 21224, USA.
Schizophr Res. 2012 Aug;139(1-3):194-200. doi: 10.1016/j.schres.2012.04.012. Epub 2012 May 14.
The prevalence of cigarette smoking among people with schizophrenia is greater than that of the general population. Because smoking and use of other drugs covary, we examined illicit drug use in current smokers not trying to quit or reduce their tobacco use. We recruited outpatient participants who had a DSM-IV diagnosis of schizophrenia or schizoaffective disorder (schizophrenia, n=70) and a control group who had no Axis I psychiatric disorders (control, n=97). During a 2-3-hour session, participants completed demographic and research questionnaires, including the Drug Use Survey (DUS).
Participants with schizophrenia were older than controls (p<0.001) and smoked more cigarettes per day (p=0.01), but did not differ in degree of nicotine dependence. Ever using a drug was similar between the groups, except that significantly more participants with schizophrenia reported ever using hallucinogens (p<0.001) and inhalants (p=0.001). For alcohol, cocaine, and marijuana, fewer participants with schizophrenia were current users, but more participants with schizophrenia were past users (ps<0.0001). Heavy smokers from the general population continued to use illicit drugs throughout their lives, while schizophrenia participants had the highest period of illicit drug use in their 20s.
These data suggest that illicit drug use tends to be high in heavy cigarette smokers, regardless of a schizophrenia diagnosis. However, while illicit drug use is high across the lifespan of heavy smokers in the general population, heavy smokers with schizophrenia use illicit drugs mostly in the first decade of their illness.
精神分裂症患者的吸烟率高于一般人群。由于吸烟和使用其他毒品存在共变关系,我们研究了当前试图戒烟或减少烟草使用的吸烟者中的非法药物使用情况。我们招募了门诊参与者,他们有DSM-IV 诊断的精神分裂症或分裂情感障碍(精神分裂症,n=70)和没有任何轴 I 精神障碍的对照组(对照组,n=97)。在 2-3 小时的会议期间,参与者完成了人口统计学和研究问卷,包括药物使用调查(DUS)。
精神分裂症患者比对照组年龄更大(p<0.001),每天吸烟更多(p=0.01),但尼古丁依赖程度无差异。两组之间曾经使用过药物的情况相似,除了精神分裂症患者报告曾经使用过致幻剂(p<0.001)和吸入剂(p=0.001)的比例明显更高。对于酒精、可卡因和大麻,精神分裂症患者的现用者较少,但既往使用者更多(p<0.0001)。一般人群中的重度吸烟者在其一生中继续使用非法药物,而精神分裂症患者在 20 多岁时的非法药物使用期最长。
这些数据表明,无论是否患有精神分裂症,非法药物使用在重度吸烟者中往往很高。然而,虽然一般人群中的重度吸烟者在其一生中非法药物使用量很高,但患有精神分裂症的重度吸烟者主要在发病的第一个十年使用非法药物。